1492 CAPITAL MANAGEMENT LLC – CRISPR Therapeutics AG Transaction History
1492 CAPITAL MANAGEMENT LLC portfolio value:
$785,000
portfolio value
1492 CAPITAL MANAGEMENT LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.02% | -3 shares | 55K | $65.35 | 12.00K |
| Q2 2022 | share | Increase | 0.00% | 12.00K shares | 730K | $60.77 | 12.00K |
| Q4 2021 | share | Decrease | -100.00% | -9.25K shares | -1.03M | $78.85 | 0 |
| Q3 2021 | share | Decrease | -0.73% | -68 shares | -473K | $111.93 | 9.25K |
| Q2 2021 | share | Increase | +174.24% | 5.92K shares | 1.09M | $161.89 | 9.32K |
| Q1 2021 | share | Decrease | -2.30% | -80 shares | -119K | $121.85 | 3.4K |
| Q4 2020 | share | Decrease | -62.51% | -5.80K shares | -243K | $153.11 | 3.48K |
| Q3 2020 | share | Increase | +8.55% | 731 shares | 148K | $83.64 | 9.28K |
| Q2 2020 | share | Decrease | -0.50% | -43 shares | 263K | $73.49 | 8.55K |
| Q1 2020 | share | Decrease | -2.21% | -194 shares | -170K | $42.41 | 8.59K |
| Q4 2019 | share | Increase | 0.00% | 8.78K shares | 535K | $60.91 | 8.78K |
| Q1 2019 | share | Decrease | -100.00% | -15.63K shares | -447K | $35.72 | 0 |
| Q4 2018 | share | Decrease | -12.00% | -2.13K shares | -341K | $28.57 | 15.63K |
| Q3 2018 | share | Increase | 0.00% | 17.76K shares | 788K | $44.35 | 17.76K |